Radar Technology Company Xandar Kardian and TapestryHealth Announce Strategic Partnership to Provide Specialized Remote Patient Monitoring

In a key example, a Xandar Kardian XK300 device installed in a registered patient’s room several sustained elevations in resting heart rate that occurred throughout the week prior to his cardiac arrest. This finding illustrates that resting heart rate shows warning signals much earlier than respiratory rate, even when the patient is at rest. Because the XK300 records these data points more than 6,000 times in every 24-hour period, the information is highly accurate and provides medical personnel with real-time data to monitor for these potential early signals. Then “it’s time to act” was signaled when the patient respiratory rate levels were at a sustained elevation of over 20 breaths per minute for over six hours. Therefore, the combined data provided by the XK300’s reports of the patient’s resting heart rate and respiratory rate could have enabled intervention. within the first six hours of respiratory rate deterioration, rather than allowing deterioration to continue for more than 50 hourswhich resulted in the resident being rushed to the emergency room after peaking at 30 breaths per minute.

Additionally, since the UWB radar requires no patient reporting, wearables, or staff intervention, this information is provided to nurses without them having to make rounds or disturb the patient. dr. Ashwin Gopalan, a pulmonologist at Virginia Mason Seattle, highlights how using this resting heart rate data provided by the XK300 can transform early detection and reduce medical crises in healthcare centers where patient reports and wearable devices can be barriers to collecting accurate data. “When dealing with patients with the type of acute and chronic conditions common in skilled nursing settings such as COPD, pneumonia and CHF, a change in resting heart rate or heart rate breathing is the clearest indicator of disease exacerbation.What Xandar Kardian and TapestryHealth Pilot revealed, however, is that we can rely on resting heart rate data much sooner than before. these continuous measurements and to a more precise degree than ever before are a game-changer in avoiding emergency room visits and re-hospitalizations, especially for establishments that follow dozens of patients at a time.

Xandar Kardian’s XK300 devices are the only commercially available FDA 510(k) Class II medical devices authorized for monitoring resting heart rate, respiratory rate, motion, and presence. The device uses ultra-wideband radar, a type of radar that transmits signals with shorter pulses over a wider spectrum for extremely precise data accuracy and fast transmission speeds, to detect micromovements of the heart of ‘a person who beats or pumps the lungs in a room up to 0.1 mm changes per nanosecond. Collected data is immediately processed by Xandar Kardian’s proprietary DSP algorithms for consistent, non-contact, autonomous and immediate delivery of patient vital signs data at a rate of thousands of measurements per day. Additionally, Xandar Kardian’s devices do not use AI logic to gather vital signs information, as this often leads to inconsistencies with the results.

TapestryHealth co-founder and chief growth officer Mordy Eisenberg says Xandar Kardian’s technology has become an essential complement for clinicians who now operate despite staff shortages. “The state of health care today is that we are in a fragmented care system – people are sicker than before and there is a widespread shortage of health care workers,” he said. . “The combination of sicker patients and fewer staff has resulted in clinicians missing out on critical warning signs of medical crises. That’s where the XK300 comes in. Xandar Kardian’s technology is enable by empowering our clinicians to anticipate crises, empowering our staff to do more with less so they can deliver consistent, high-end care and stop medical emergencies before they happen, despite the reduced number of staff available. Ultimately, the XK300 is a key tool that augments the small workforce that has become the new norm. »

The partnership between Xandar Kardian and TapestryHealth enables skilled nursing and assisted living facilities to easily add additional remote clinical support for their residents with minimal cost or staff disruption. For appropriate patients, using CPT code 99454, the XK300 system is eligible for Medicare and Medicaid reimbursement as an FDA-approved medical device.

To learn more about Xandar Kardian and the XK300 standalone health monitoring solution, visit the Xandar Kardian website at www.xkcorp.com.

About Xandar Kardian:
Xandar Kardian is an American C-Corp from Delaware with international operations spanning South Korea, Canadaand Singapore, focused on deploying reliable, high-precision healthcare and security solutions worldwide. Xandar Kardian takes motion sensor technology to the next level, incorporating radar sensors that monitor vital signs via resting heart rate (RHR) and respiratory rate (RR), providing critical information about movement, location and reading the occupants’ vital signs. Founded in 2017, the team behind Xandar Kardian is focused on digital radar signal processing from start to finish, having received FDA 510(k) clearance for its XK300 in April 2021.

About TapestryHealth:
TapestryHealth is a multi-specialty healthcare practice that uses state-of-the-art technology to provide face-to-face bedside assessment and treatment in skilled nursing facilities and other post-acute settings. Tapestry’s team of physicians, PAs, NPs, and multiple medical specialists sees patients at their bedside, 24/7, making daily rounds, building relationships with patients and families based on familiarity and trust, and ensuring appropriate, effective and efficient care delivery. of the patient’s location, or the day and time of need. They are one of the nation’s leading innovators in using technology to provide advanced care both onsite and remotely. Tapestry’s artificial intelligence and machine learning protocols provide in-depth analysis at the patient, facility, and national level, allowing them to identify potentially at-risk patients before symptoms appear. They are currently testing robotics and other advances for independent data collection, allowing nurses to spend more time with their patients. Learn more about tapestryhealth.com.

Ruben Marinbach
Account director
GreenRoom Agency
[email protected]
305-347-1787 Ext. 305

SOURCEXandar Kardian

Comments are closed.